Biomarin Pharmaceutical: Q3 Earnings Insights

Biomarin Pharmaceutical BMRN reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Biomarin Pharmaceutical beat their estimated earnings by 20.0%, reporting an EPS of $-0.2 versus an estimate of $-0.25, which surprised analysts.

Revenue was up $68,042,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.18, which was followed by a 0.28% drop in the share price the next day.

Here's a look at Biomarin Pharmaceutical's past performance:

 

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.11 -0.10 -0.19 1.29
EPS Actual 0.07 0.09 0.12 4.01
Revenue Estimate 448.79M 446.45M 440.23M 454.64M
Revenue Actual 501.69M 486.03M 452.12M 476.78M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!